Literature DB >> 17566346

[Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases].

.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17566346

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  17 in total

1.  Comparison of clinical features and polysomnographic findings between men and women with sleep apnea.

Authors:  Shiho Yamakoshi; Takatoshi Kasai; Yasuhiro Tomita; Hisashi Takaya; Satoshi Kasagi; Masateru Kawabata; Koji Narui; Yasuhiro Setoguchi
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

2.  Association between frequency of drinking alcohol and chronic kidney disease in men.

Authors:  Yayoi Funakoshi; Hisamitsu Omori; Ayumi Onoue; Shuichi Mihara; Yasuhiro Ogata; Takahiko Katoh
Journal:  Environ Health Prev Med       Date:  2011-08-31       Impact factor: 3.674

3.  C-reactive protein levels, airflow obstruction, and chronic kidney disease.

Authors:  Yayoi Funakoshi; Hisamitsu Omori; Shuichi Mihara; Ayumi Onoue; Yasuhiro Ogata; Hisamichi Aizawa; Takahiko Katoh
Journal:  Environ Health Prev Med       Date:  2011-04-21       Impact factor: 3.674

4.  Relationship of hepatic steatosis severity and coronary artery disease characteristics assessed by coronary CT angiography.

Authors:  Nobuo Tomizawa; Shinichi Inoh; Takeshi Nojo; Sunao Nakamura
Journal:  Int J Cardiovasc Imaging       Date:  2016-01-30       Impact factor: 2.357

5.  Combination treatment of rosuvastatin or atorvastatin, with regular exercise improves arterial wall stiffness in patients with coronary artery disease.

Authors:  Kensuke Toyama; Seigo Sugiyama; Hideki Oka; Yuri Iwasaki; Hitoshi Sumida; Tomoko Tanaka; Shinji Tayama; Hideaki Jinnouchi; Hisao Ogawa
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

6.  Cardiovascular risk management with liaison critical path in Japan: its effects on implementation of evidence-based prevention in practice.

Authors:  Morihiro Matsuda; Manami Akizuki; Orie Nishimoto; Kei Nakamoto; Hirohiko Nishiyama; Ritsu Tamura; Toshiharu Kawamoto
Journal:  J Clin Med Res       Date:  2012-03-23

7.  Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.

Authors:  Kentaro Sakamoto; Mitsunobu Kawamura; Takahide Kohro; Masao Omura; Takayuki Watanabe; Keiko Ashidate; Toshiyuki Horiuchi; Hidehiko Hara; Nobuo Sekine; Rina Chin; Motoyoshi Tsujino; Toru Hiyoshi; Motoki Tagami; Akira Tanaka; Yasumichi Mori; Takeshi Inazawa; Tsutomu Hirano; Tsutomu Yamazaki; Teruo Shiba
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

8.  Characterization of clinical and genetic risk factors associated with dyslipidemia after kidney transplantation.

Authors:  Kazuyuki Numakura; Hideaki Kagaya; Ryohei Yamamoto; Naoki Komine; Mitsuru Saito; Tsuruta Hiroshi; Susumu Akihama; Takamitsu Inoue; Shintaro Narita; Norihiko Tsuchiya; Tomonori Habuchi; Takenori Niioka; Masatomo Miura; Shigeru Satoh
Journal:  Dis Markers       Date:  2015-04-06       Impact factor: 3.434

9.  Association of serum carotenoid levels with urinary albumin excretion in a general Japanese population: the Yakumo study.

Authors:  Koji Suzuki; Hisashi Honjo; Naohiro Ichino; Keisuke Osakabe; Keiko Sugimoto; Hiroya Yamada; Yasuhiro Kusuhara; Rika Watarai; Takeshi Hamajima; Nobuyuki Hamajima; Takashi Inoue
Journal:  J Epidemiol       Date:  2013-10-05       Impact factor: 3.211

10.  Association between serum levels of carotenoids and serum asymmetric dimethylarginine levels in Japanese subjects.

Authors:  Rika Watarai; Koji Suzuki; Naohiro Ichino; Keisuke Osakabe; Keiko Sugimoto; Hiroya Yamada; Takeshi Hamajima; Nobuyuki Hamajima; Takashi Inoue
Journal:  J Epidemiol       Date:  2014-04-12       Impact factor: 3.211
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.